In vivo pharmacokinetic analysis of meropenem/vaborbactam during continuous venovenous haemodialysis.
作者： Wesley D Kufel , Ambika P Eranki , Kristopher M Paolino , Andrea Call , Christopher D Miller
DOI: 10.1093/JAC/DKZ103
关键词:
摘要:
oup.com
sci-hub.se 参考文章(9)
Joseph L. Kuti, David P. Nicolau, Derivation of Meropenem Dosage in Patients Receiving Continuous Veno-Venous Hemofiltration Based on Pharmacodynamic Target Attainment Chemotherapy. ,vol. 51, pp. 211- 216 ,(2005) , 10.1159/000086598
Yong Zhang, Meirong Huo, Jianping Zhou, Shaofei Xie, PKSolver: An add-in program for pharmacokinetic and pharmacodynamic data analysis in Microsoft Excel Computer Methods and Programs in Biomedicine. ,vol. 99, pp. 306- 314 ,(2010) , 10.1016/J.CMPB.2010.01.007
Mariann D. Churchwell, Use of an In Vitro Model of Renal Replacement Therapy Systems to Estimate Extracorporeal Drug Removal The Journal of Clinical Pharmacology. ,vol. 52, ,(2012) , 10.1177/0091270011415979
Eric Wenzler, Mark H. Gotfried, Jeffrey S. Loutit, Stephanie Durso, David C. Griffith, Michael N. Dudley, Keith A. Rodvold, Meropenem-RPX7009 Concentrations in Plasma, Epithelial Lining Fluid, and Alveolar Macrophages of Healthy Adult Subjects Antimicrobial Agents and Chemotherapy. ,vol. 59, pp. 7232- 7239 ,(2015) , 10.1128/AAC.01713-15
Elizabeth A. Neuner, Jason C. Gallagher, Pharmacodynamic and pharmacokinetic considerations in the treatment of critically Ill patients infected with carbapenem-resistant Enterobacteriaceae. Virulence. ,vol. 8, pp. 440- 452 ,(2017) , 10.1080/21505594.2016.1221021
Christopher M. Rubino, Sujata M. Bhavnani, Jeffery S. Loutit, Brooke Lohse, Michael N. Dudley, David C. Griffith, Single-Dose Pharmacokinetics and Safety of Meropenem-Vaborbactam in Subjects with Chronic Renal Impairment. Antimicrobial Agents and Chemotherapy. ,vol. 62, ,(2018) , 10.1128/AAC.02103-17
Jason M Pogue, Robert A Bonomo, Keith S Kaye, Ceftazidime/Avibactam, Meropenem/Vaborbactam, or Both? Clinical and Formulary Considerations. Clinical Infectious Diseases. ,vol. 68, pp. 519- 524 ,(2019) , 10.1093/CID/CIY576
Fekade B. Sime, Saurabh Pandey, Nermin Karamujic, Suzanne Parker, Elizabeth Alexander, Jeffery Loutit, Stephanie Durso, David Griffith, Jeffrey Lipman, Steven C. Wallis, Jason A. Roberts, Ex Vivo Characterization of Effects of Renal Replacement Therapy Modalities and Settings on Pharmacokinetics of Meropenem and Vaborbactam. Antimicrobial Agents and Chemotherapy. ,vol. 62, ,(2018) , 10.1128/AAC.01306-18
Sarah C J Jorgensen, Philip McDonald, Ryan P Mynatt, Jason M Pogue, Stephen A Lerner, Sorabh Dhar, Hossein Salimnia, Michael J Rybak, Averting the post-antibiotic era: successful use of meropenem/vaborbactam for carbapenem-resistant Serratia marcescens and Enterobacter aerogenes bacteraemia in a haemodialysis patient Journal of Antimicrobial Chemotherapy. ,vol. 73, pp. 3529- 3531 ,(2018) , 10.1093/JAC/DKY346